Ovaprene has the Potential to be the First FDA-Approved Monthly, Self-Administered, Hormone-Free Contraceptive ProductSAN DIEGO, Dec. 04, 2023 (GLOBE NEWSWIRE)…
SAINT LAURENT, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces…
LAS VEGAS, NV / ACCESSWIRE / December 4, 2023 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1…
MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Bahrain has become the second country in the world and the first…
VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it…
SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE:…
CHICAGO, IL / ACCESSWIRE / December 1, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…
STOCKHOLM, SWEDEN / ACCESSWIRE / December 01, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Bosse Johansson, acquired 800,000…
Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of…